Asano K, Lilly C M, O'Donnell W J, Israel E, Fischer A, Ransil B J, Drazen J M
Combined Program in Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):643-51. doi: 10.1016/s0091-6749(95)70263-6.
Leukotriene E4 (LTE4) and histamine excreted into the urine reflect the in vivo synthesis and release of cysteinyl leukotrienes and histamine, respectively. We examined the diurnal variation of the excretion rate of these mediators over 4 consecutive days in normal subjects (n = 5) and patients with stable mild-to-moderate asthma (n = 8).
Sixteen consecutive 6-hour urine samples were collected over 4 days. Urinary LTE4 concentrations were determined by reverse-phase high-pressure liquid chromatography, followed by ELISA. Urinary histamine concentrations were measured by ELISA. The excretion rates of these compounds were normalized relative to urinary creatinine content.
The mean urinary LTE4 excretion rate was 83.8 +/- 38.2 pg/mg creatinine (mean +/- SD) in normal subjects; in patients with asthma, the urinary LTE4 excretion rate (110.0 +/- 59.2 pg/mg creatinine) was significantly higher than that in normal subjects (p < 0.05). The urinary histamine excretion rate was not different between normal subjects (24.0 +/- 12.5 ng/mg creatinine) and patients with asthma (31.5 +/- 25.8 ng/mg creatinine). A robust and systematic within-day variation (p < 0.01), but no day-to-day variation, was observed in histamine excretion rate. Although the magnitude of variation in LTE4 excretion within a day was significantly greater in patients with asthma than in normal subjects (p < 0.05), we could not identify any specific diurnal variation pattern in either the normal or the asthma group. No significant correlation was observed between urinary LTE4 and histamine excretion rate within any subject.
Patients with asthma excrete LTE4 in the urine at a greater rate than normal subjects. Although no systematic variation in urinary LTE4 excretion rates over the course of a day was observed in either normal subjects or patients with stable asthma, the presence of a systematic diurnal variation of urinary histamine excretion exists in both groups.
尿液中排泄的白三烯E4(LTE4)和组胺分别反映了半胱氨酰白三烯和组胺在体内的合成与释放。我们在正常受试者(n = 5)和稳定的轻至中度哮喘患者(n = 8)中连续4天检测了这些介质排泄率的昼夜变化。
在4天内连续收集16份6小时尿液样本。通过反相高压液相色谱法测定尿LTE4浓度,随后进行酶联免疫吸附测定(ELISA)。通过ELISA测量尿组胺浓度。这些化合物的排泄率相对于尿肌酐含量进行标准化。
正常受试者尿LTE4平均排泄率为83.8±38.2 pg/mg肌酐(平均值±标准差);哮喘患者尿LTE4排泄率(110.0±59.2 pg/mg肌酐)显著高于正常受试者(p < 0.05)。正常受试者(24.0±12.5 ng/mg肌酐)和哮喘患者(31.5±25.8 ng/mg肌酐)的尿组胺排泄率无差异。在组胺排泄率中观察到强烈且有规律的日内变化(p < 0.01),但无日间变化。尽管哮喘患者一天内LTE4排泄变化幅度显著大于正常受试者(p < 0.05),但我们在正常组或哮喘组中均未发现任何特定的昼夜变化模式。在任何受试者中,尿LTE4与组胺排泄率之间均未观察到显著相关性。
哮喘患者尿液中LTE4排泄率高于正常受试者。尽管在正常受试者或稳定哮喘患者中均未观察到一天内尿LTE4排泄率的系统性变化,但两组中均存在尿组胺排泄的系统性昼夜变化。